Ventricular-Vascular Interaction in Heart Failure

Cardiology Clinics

Volumn 29, Issue 3, 2011, Pages 447-459

  Borlaug, Barry A ^a   Kass, David A ^b  

^a MAYO CLINIC   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Preserved ejection fraction; Ventriculorterial stiffening; Verapamil

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FASUDIL; HYDROCHLOROTHIAZIDE; LOSARTAN; SILDENAFIL; SPIRONOLACTONE; VERAPAMIL;

AEROBIC EXERCISE; ARTERY COMPLIANCE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; DRUG EFFICACY; HEART FAILURE; HEART FAILURE WITH A PRESERVED EJECTION FRACTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE COMPLIANCE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART OUTPUT; HEART STROKE VOLUME; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPERTROPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYSTOLIC BLOOD PRESSURE; VENTRICULOARTERIAL STIFFENING;

EID: 79960756306     PISSN: 07338651     EISSN: 15582264     Source Type: Journal    
DOI: 10.1016/j.ccl.2011.06.004     Document Type: Review

References (73)

1. Suga H., Sagawa K. Instantaneous pressure-volume relationships and their ratio in the excised, supported canine left ventricle. Circ Res 1974, 35(1):117-126.
2. Kass D.A., Kelly R.P. Ventriculo-arterial coupling: concepts, assumptions, and applications. Ann Biomed Eng 1992, 20(1):41-62.
3. Milnor W.R. Arterial impedance as ventricular afterload. Circ Res 1975, 36(5):565-570.
4. Murgo J.P., Westerhof N., Giolma J.P., et al. Aortic input impedance in normal man: relationship to pressure wave forms. Circulation 1980, 62(1):105-116.
5. Sunagawa K., Maughan W.L., Burkhoff D., et al. Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol 1983, 245(5 Pt 1):H773-H780.
6. Sunagawa K., Maughan W.L., Sagawa K. Optimal arterial resistance for the maximal stroke work studied in isolated canine left ventricle. Circ Res 1985, 56(4):586-595.
7. Kelly R.P., Ting C.T., Yang T.M., et al. Effective arterial elastance as index of arterial vascular load in humans. Circulation 1992, 86(2):513-521.
8. Asanoi H., Sasayama S., Kameyama T. Ventriculoarterial coupling in normal and failing heart in humans. Circ Res 1989, 65(2):483-493.
9. De Tombe P.P., Jones S., Burkhoff D., et al. Ventricular stroke work and efficiency both remain nearly optimal despite altered vascular loading. Am J Physiol 1993, 264(6 Pt 2):H1817-H1824.
10. Redfield M.M., Jacobsen S.J., Borlaug B.A., et al. Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation 2005, 112(15):2254-2262.
11. Najjar S.S., Schulman S.P., Gerstenblith G., et al. Age and gender affect ventricular-vascular coupling during aerobic exercise. J Am Coll Cardiol 2004, 44(3):611-617.
12. Avolio A.P., Chen S.G., Wang R.P., et al. Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation 1983, 68(1):50-58.
13. Chen C.H., Nakayama M., Nevo E., et al. Coupled systolic-ventricular and vascular stiffening with age: implications for pressure regulation and cardiac reserve in the elderly. J Am Coll Cardiol 1998, 32(5):1221-1227.
14. Nichols W.W., O'Rourke M.F., Avolio A.P., et al. Effects of age on ventricular-vascular coupling. Am J Cardiol 1985, 55(9):1179-1184.
15. Kawaguchi M., Hay I., Fetics B., et al. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 2003, 107(5):714-720.
16. Nichols W.W., O'Rourke M.F., Avolio A.P., et al. Ventricular/vascular interaction in patients with mild systemic hypertension and normal peripheral resistance. Circulation 1986, 74(3):455-462.
17. Segers P., Stergiopulos N., Westerhof N. Relation of effective arterial elastance to arterial system properties. Am J Physiol Heart Circ Physiol 2002, 282(3):H1041-H1046.
18. Chemla D., Antony I., Lecarpentier Y., et al. Contribution of systemic vascular resistance and total arterial compliance to effective arterial elastance in humans. Am J Physiol Heart Circ Physiol 2003, 285(2):H614-H620.
19. Kelly R., Hayward C., Avolio A., et al. Noninvasive determination of age-related changes in the human arterial pulse. Circulation 1989, 80(6):1652-1659.
20. Borlaug B.A., Melenovsky V., Redfield M.M., et al. The impact of arterial load and loading sequence on left ventricular tissue velocities in humans. J Am Coll Card 2007, 50(16):1570-1577.
21. Melenovsky V., Borlaug B.A., Rosen B., et al. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction. J Am Coll Cardiol 2007, 49(2):198-207.
22. Lam C.S., Roger V.L., Rodeheffer R.J., et al. Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted county, Minnesota. Circulation 2007, 115(15):1982-1990.
23. Zile M.R., Baicu C.F., Gaasch W.H. Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004, 350(19):1953-1959.
24. Borlaug B.A., Kass D.A. Mechanisms of diastolic dysfunction in heart failure. Trends Cardiovasc Med 2006, 16(8):273-279.
25. Zieman S.J., Melenovsky V., Kass D.A. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005, 25(5):932-943.
26. Owan T.E., Redfield M.M. Epidemiology of diastolic heart failure. Prog Cardiovasc Dis 2005, 47(5):320-332.
27. Klapholz M., Maurer M., Lowe A.M., et al. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York heart failure registry. J Am Coll Cardiol 2004, 43(8):1432-1438.
28. Borbely A., van der Velden J., Papp Z., et al. Cardiomyocyte stiffness in diastolic heart failure. Circulation 2005, 111(6):774-781.
29. van Heerebeek L., Borbely A., Niessen H.W., et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 2006, 113(16):1966-1973.
30. Dauterman K., Pak P.H., Maughan W.L., et al. Contribution of external forces to left ventricular diastolic pressure. Implications for the clinical use of the Starling law. Ann Intern Med 1995, 122(10):737-742.
31. Gandhi S.K., Powers J.C., Nomeir A.M., et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001, 344(1):17-22.
32. Carroll J.D., Carroll E.P., Feldman T., et al. Sex-associated differences in left ventricular function in aortic stenosis of the elderly. Circulation 1992, 86(4):1099-1107.
33. Villari B., Campbell S.E., Schneider J., et al. Sex-dependent differences in left ventricular function and structure in chronic pressure overload. Eur Heart J 1995, 16(10):1410-1419.
34. Kass D.A., Maughan W.L. From "Emax" to pressure-volume relations: a broader view. Circulation 1988, 77(6):1203-1212.
35. Franciosa J.A., Leddy C.L., Wilen M., et al. Relation between hemodynamic and ventilatory responses in determining exercise capacity in severe congestive heart failure. Am J Cardiol 1984, 53(1):127-134.
36. Borlaug B.A., Melenovsky V., Russell S.D., et al. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 2006, 114(20):2138-2147.
37. Gillebert T.C., Leite-Moreira A.F., De Hert S.G. Load dependent diastolic dysfunction in heart failure. Heart Fail Rev 2000, 5(4):345-355.
38. Gillebert T.C., Lew W.Y. Influence of systolic pressure profile on rate of left ventricular pressure fall. Am J Physiol 1991, 261(3 Pt 2):H805-H813.
39. Leite-Moreira A.F., Correia-Pinto J., Gillebert T.C. Afterload induced changes in myocardial relaxation: a mechanism for diastolic dysfunction. Cardiovasc Res 1999, 43(2):344-353.
40. Takimoto E., Soergel D.G., Janssen P.M., et al. Frequency- and afterload-dependent cardiac modulation in vivo by troponin I with constitutively active protein kinase A phosphorylation sites. Circ Res 2004, 94(4):496-504.
41. Bilchick K.C., Duncan J.G., Ravi R., et al. Heart failure-associated alterations in troponin I phosphorylation impair ventricular relaxation-afterload and force-frequency responses and systolic function. Am J Physiol Heart Circ Physiol 2007, 292(1):H318-H325.
42. Brutsaert D.L., Sys S.U. Relaxation and diastole of the heart. Physiol Rev 1989, 69(4):1228-1315.
43. Solomon S.D., Janardhanan R., Verma A., et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet 2007, 369(9579):2079-2087.
44. Gilbert J.C., Glantz S.A. Determinants of left ventricular filling and of the diastolic pressure-volume relation. Circ Res 1989, 64(5):827-852.
45. Kass D.A., Wolff M.R., Ting C.T., et al. Diastolic compliance of hypertrophied ventricle is not acutely altered by pharmacologic agents influencing active processes. Ann Intern Med 1993, 119(6):466-473.
46. Leite-Moreira A.F., Correia-Pinto J. Load as an acute determinant of end-diastolic pressure-volume relation. Am J Physiol Heart Circ Physiol 2001, 280(1):H51-H59.
47. Shapiro B.P., Lam C.S., Patel J.B., et al. Acute and chronic ventricular-arterial coupling in systole and diastole. Insights from an elderly hypertensive model. Hypertension 2007, 50(3):503-511.
48. Saeki A., Recchia F., Kass D.A. Systolic flow augmentation in hearts ejecting into a model of stiff aging vasculature. Influence on myocardial perfusion-demand balance. Circ Res 1995, 76(1):132-141.
49. Kass D.A., Saeki A., Tunin R.S., et al. Adverse influence of systemic vascular stiffening on cardiac dysfunction and adaptation to acute coronary occlusion. Circulation 1996, 93(8):1533-1541.
50. Li M., Chiou K.R., Bugayenko A., et al. Reduced wall compliance suppresses Akt-dependent apoptosis protection stimulated by pulse perfusion. Circ Res 2005, 97(6):587-595.
51. Warner J.G., Metzger D.C., Kitzman D.W., et al. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol 1999, 33(6):1567-1572.
52. Little W.C., Zile M.R., Klein A., et al. Effect of losartan and hydrochlorothiazide on exercise tolerance in exertional hypertension and left ventricular diastolic dysfunction. Am J Cardiol 2006, 98(3):383-385.
53. Hundley W.G., Kitzman D.W., Morgan T.M., et al. Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol 2001, 38(3):796-802.
54. Jaber W.A., Borlaug B.A., Redfield M.M., et al. Determination of the mechanism of elevated left ventricular filling pressures with exercise: a simultaneous echocardiographic-catheterization study. Circulation 2007, 116:371. [abstract 1756].
55. Bonow R.O., Dilsizian V., Rosing D.R., et al. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. Circulation 1985, 72(4):853-864.
56. Setaro J.F., Zaret B.L., Schulman D.S., et al. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol 1990, 66(12):981-986.
57. Chen C.H., Nakayama M., Talbot M., et al. Verapamil acutely reduces ventricular-vascular stiffening and improves aerobic exercise performance in elderly individuals. J Am Coll Cardiol 1999, 33(6):1602-1609.
58. Nussbacher A., Gerstenblith G., O'Connor F.C., et al. Hemodynamic effects of unloading the old heart. Am J Physiol 1999, 277(5 Pt 2):H1863-H1871.
59. Fleg J.L., Schulman S., O'Connor F., et al. Effects of acute beta-adrenergic receptor blockade on age-associated changes in cardiovascular performance during dynamic exercise. Circulation 1994, 90(5):2333-2341.
60. Brubaker P.H., Joo K.C., Stewart K.P., et al. Chronotropic incompetence and its contribution to exercise intolerance in older heart failure patients. J Cardiopulm Rehabil 2006, 26(2):86-89.
61. Kass D.A. Ventricular arterial stiffening: integrating the pathophysiology. Hypertension 2005, 46(1):185-193.
62. Yusuf S., Pfeffer M.A., Swedberg K., et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003, 362(9386):777-781.
63. Cleland J.G., Tendera M., Adamus J., et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006, 27(19):2338-2345.
64. Pitt B., Reichek N., Willenbrock R., et al. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation 2003, 108(15):1831-1838.
65. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999, 341(10):709-717.
66. Kuwahara F., Kai H., Tokuda K., et al. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 2002, 106(1):130-135.
67. Matsumoto T., Wada A., Tsutamoto T., et al. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure. Circulation 2003, 107(20):2555-2558.
68. Lai A., Frishman W.H. Rho-kinase inhibition in the therapy of cardiovascular disease. Cardiol Rev 2005, 13(6):285-292.
69. Higashi M., Shimokawa H., Hattori T., et al. Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ Res 2003, 93(8):767-775.
70. Morikawa-Futamatsu K., Adachi S., Maejima Y., et al. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1. Life Sci 2006, 79(14):1380-1390.
71. Fukuta H., Sane D.C., Brucks S., et al. Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report. Circulation 2005, 112(3):357-363.
72. Takimoto E., Champion H.C., Li M., et al. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med 2005, 11(2):214-222.
73. Borlaug B.A., Melenovsky V., Marhin T., et al. Sildenafil inhibits beta-adrenergic-stimulated cardiac contractility in humans. Circulation 2005, 112(17):2642-2649.